logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

IPT during HIV treatment in Myanmar: high rates of coverage, completion and drug adherence

Ousley J, Soe KT, Kyaw NTT, Anicete R, Mon PE,  et al.
2018-03-21 • Public Health Action
2018-03-21 • Public Health Action
Setting: A southern Myanmar district providing isoniazid preventive therapy (IPT) in one of the last countries to formally recommend it as part of human immunodeficiency virus (HIV) care...
Journal Article
|
Research

Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar

Thi AM, Shewade HD, Kyaw NTT, Oo MM, Aung TK,  et al.
2016-06-21 • Public Health Action
2016-06-21 • Public Health Action
SETTING
Integrated HIV Care programme, Mandalay, Myanmar.

OBJECTIVES
To determine time to starting antiretroviral treatment (ART) in relation to anti-tuberculosis treatm...
Journal Article
|
Research

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial

Smithuis FM, Kyaw MK, Phe O, Win T, Aung PP,  et al.
2010-10-01 • Lancet Infectious Diseases
2010-10-01 • Lancet Infectious Diseases
BACKGROUND: Artemisinin-combination therapy (ACT) is recommended as first-line treatment of falciparum malaria throughout the world, and fixed-dose combinations are preferred by WHO; whe...